GILD

2025Q1AMC

Gilead Sciences Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2025-04-24 · Fiscal end 2025-03-31 · Features as of 2025-04-24

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS1.78
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move2.0%
IV front—
P/C full—
P/C front—
Features as of2025-04-24

Run-up

Close—
Ret 5d+1.2%
Ret 10d+0.9%
Ret 20d-2.9%
Ret 30d-6.9%

Post-Earnings Data

Results & reaction

Print

Actual EPS
1.81Beat
Estimated EPS1.78
Actual revenue
6.7B
Surprise %+1.7%
Beat / missBeat
Beat streak 44
Beat streak 85

Reaction

1-day stock reaction+0.5%
Implied vs actual

Implied 2.0%Actual 3.3%

Gap reaction-3.3%
Day result-2.8%
Next-day upYes
Realized / IV1.62×

Post tape

Post 5d+0.5%
Post 10d-6.1%
Post volume14.2M
Vol ×10d1.68×
Vol ×20d1.50×
Post range10.5%